These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
116 related articles for article (PubMed ID: 21751552)
1. [Intravenous immunoglobulin therapy for kidney diseases in children]. Zwolińska D Pol Merkur Lekarski; 2011 Jun; 30(180):423-6. PubMed ID: 21751552 [TBL] [Abstract][Full Text] [Related]
2. Hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP) complicating adult Still's disease: remission induced with intravenous immunoglobulin G. Diamond JR J Nephrol; 1997; 10(5):253-7. PubMed ID: 9364316 [TBL] [Abstract][Full Text] [Related]
3. Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Finazzi G; Bellavita P; Falanga A; Viero P; Barbui T Am J Hematol; 1992 Nov; 41(3):165-9. PubMed ID: 1415190 [TBL] [Abstract][Full Text] [Related]
4. Treatment of an infant with severe acute refractory immune thrombocytopenic purpura using combination therapy including rituximab. Iesato K; Hatakeyama N; Yamamoto M; Hori T; Inazawa N; Tsutsumi H; Suzuki N Pediatr Blood Cancer; 2009 Aug; 53(2):203-5. PubMed ID: 19301247 [TBL] [Abstract][Full Text] [Related]
6. [Treatment of thrombotic microangiopathies]. Debourdeau P; Zammit C; Souleau B; Védrine L; Farge-Bancel D Ann Med Interne (Paris); 1999 Sep; 150(5):374-87. PubMed ID: 10544747 [TBL] [Abstract][Full Text] [Related]
7. Treatment of childhood acute immune thrombocytopenic purpura with high-dose methylprednisolone, intravenous immunoglobulin, or the combination of both. Gereige RS; Barrios NJ P R Health Sci J; 2000 Mar; 19(1):15-8. PubMed ID: 10761200 [TBL] [Abstract][Full Text] [Related]
16. Haemolytic uraemic syndrome with peripheral gangrene and Kawasaki disease in a 15-month-old child. Krishnamurthy S; Jagadeesh A; Chandrasekaran V; Mahadevan S; Rajesh NG Paediatr Int Child Health; 2017 Feb; 37(1):70-73. PubMed ID: 26752398 [TBL] [Abstract][Full Text] [Related]
17. The role of intravenous immunoglobulin therapy in autoimmune and inflammatory disorders. Emmi L; Chiarini F Neurol Sci; 2002 Apr; 23 Suppl 1():S1-8. PubMed ID: 12032582 [TBL] [Abstract][Full Text] [Related]
18. Results of a model analysis to estimate cost utility and value of information for intravenous immunoglobulin in Canadian adults with chronic immune thrombocytopenic purpura. Xie F; Blackhouse G; Assasi N; Campbell K; Levin M; Bowen J; Tarride JE; Pi D; Goeree R Clin Ther; 2009 May; 31(5):1082-91; discussion 1066-8. PubMed ID: 19539109 [TBL] [Abstract][Full Text] [Related]
19. Single dose of anti-D immune globulin at 75 microg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children. Tarantino MD; Young G; Bertolone SJ; Kalinyak KA; Shafer FE; Kulkarni R; Weber LC; Davis ML; Lynn H; Nugent DJ; J Pediatr; 2006 Apr; 148(4):489-94. PubMed ID: 16647411 [TBL] [Abstract][Full Text] [Related]
20. Successful management with intravenous immunoglobulins in alemtuzumab-induced acute inflammatory demyelinating neuropathy: clinical report of three patients. Castelli R; Gritti G; Cannavò A; Moreo G; Conti G; Reda G; Cortelezzi A Immunopharmacol Immunotoxicol; 2012 Aug; 34(4):717-20. PubMed ID: 22208918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]